Otoprotective effect of MnTBAP in cisplatin-induced hearing loss
Shomaila Mehmood, Pankaj Bhatia, Samson Jamesdaniel · 2026
Read Otoprotective effect of MnTBAP in cisplatin-induced hearing loss by Shomaila Mehmood, Pankaj Bhatia, Samson Jamesdaniel (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0351911.txt.
Description
Shomaila Mehmood, Pankaj Bhatia, and Samson Jamesdaniel test a rescue for hearing threatened by chemotherapy, in PLOS ONE in 2026. Cisplatin saves lives, especially in children, but it permanently damages hearing in many patients, and only one preventive drug is approved, for children only. The team gave mice cisplatin alongside MnTBAP, a compound that mimics the body's own antioxidant enzymes, and then measured hearing with electrical and acoustic tests and inspected the inner ear's cells.
Cisplatin alone scarred the system: a damage marker rose in hearing cells and their nerve partners, both cell types died back in the cochlea's middle and base, and hearing thresholds climbed. With the antioxidant aboard, those changes were prevented: hearing sensitivity held, and the cellular damage reversed. The mouse evidence strengthens the case that oxidative chemistry drives this side effect, and that a mopping up drug might one day protect adult patients too.
Catalog record
| CREATOR | Shomaila Mehmood, Pankaj Bhatia, Samson Jamesdaniel |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30875 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |